Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An iterative algorithm for metabolic network-based drug target identification.

Padmavati Sridhar1, Tamer Kahveci, Sanjay Ranka

  • 1Department of Computer and Information Science and Engineering, University of Florida, Gainesville, FL 32611, USA. psridhar@cise.ufl.edu

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|November 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STORM: spatial transcriptomics optimization by resolution via matrix factorization.

Briefings in bioinformatics·2026
Same author

SPACT: A clustering-driven multi-modal framework for survival prediction using genomic and histopathology data.

Medical image analysis·2026
Same author

Differential causal networks highlight sex-based differences in human tissues.

Briefings in bioinformatics·2025
Same author

OLTA: Optimizing bait seLection for TArgeted sequencing.

Bioinformatics (Oxford, England)·2025
Same author

QOMIC: quantum optimization for motif identification.

Bioinformatics advances·2025
Same author

Morphological profiling for drug discovery in the era of deep learning.

Briefings in bioinformatics·2024
Same journal

Trust, Reproducibility, and Progress: The Roles of Independent Blind Prediction and Assessment and Benchmarking in Computational Biology.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

The Evolving Cyberinfrastructure at the National Institutes of Health to Support Data and AI in Biomedical Research.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

Applications of AI & ML in Biomanufacturing of Cell and Gene Therapies.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

AI for Health: Leveraging Artificial Intelligence to Revolutionize Healthcare.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

Workshop Introduction: Advances of AI Methods in Single Cell Spatial Omics.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

DRIVE-KG: Enhancing variant-phenotype association discovery in understudied complex diseases using heterogeneous knowledge graphs.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
See all related articles

This study introduces a scalable algorithm to identify optimal drug targets (enzymes) for inhibiting specific compounds while minimizing side effects. The method efficiently finds near-optimal solutions for large metabolic networks.

Area of Science:

  • Bioinformatics
  • Systems Biology
  • Computational Biology

Background:

  • Drug design aims to reduce side effects by identifying specific enzymatic targets.
  • Identifying optimal enzyme targets in large metabolic networks is computationally challenging.

Purpose of the Study:

  • To develop a scalable algorithm for identifying enzyme targets to inhibit target compounds with minimal side effects.
  • To provide a computationally feasible approach for drug target identification in complex metabolic networks.

Main Methods:

  • Propose a scalable iterative algorithm that traces backward from target compounds.
  • Evaluate immediate precursors and iteratively identify enzymes for inhibition.
  • Algorithm converges to a sub-optimal solution within finite iterations.

Related Experiment Videos

Main Results:

  • The algorithm achieves high accuracy, deviating only 0.02% from exhaustive search on the E. Coli metabolic network.
  • The method is highly scalable, solving the problem for E. Coli in under 10 seconds.
  • Demonstrates effectiveness in identifying drug targets with minimal off-target effects.

Conclusions:

  • The iterative algorithm offers an efficient and scalable solution for drug target identification.
  • This approach refines drug design strategies by balancing efficacy and minimizing adverse effects.
  • Enables rapid analysis of large metabolic networks for therapeutic target discovery.